In principle, humans can produce an antibody response to any nonself-antigen molecule in the appropriate context. This flexibility is achieved by the presence of a large repertoire of naive antibodies, the diversity of which is expanded by somatic hypermutation following antigen exposure 1 . The diversity of the naive antibody repertoire in humans is estimated to be at least 10 12 unique antibodies 2 . Because the number of peripheral blood B cells in a healthy adult human is on the order of 5 × 10 9 , the circulating B cell population samples only a small fraction of this diversity. Full-scale analyses of human antibody repertoires have been prohibitively difficult, primarily owing to their massive size. The amount of information encoded by all of the rearranged antibody and T cell receptor genes in one person-the 'genome' of the adaptive immune system-exceeds the size of the human genome by more than four orders of magnitude. Furthermore, because much of the B lymphocyte population is localized in organs or tissues that cannot be comprehensively sampled from living subjects, human repertoire studies have focused on circulating B cells 3 . Here we examine the circulating B cell populations of ten human subjects and present what is, to our knowledge, the largest single collection of adaptive immune receptor sequences described to date, comprising almost 3 billion antibody heavy-chain sequences. This dataset enables genetic study of the baseline human antibody repertoire at an unprecedented depth and granularity, which reveals largely unique repertoires for each individual studied, a subpopulation of universally shared antibody clonotypes, and an exceptional overall diversity of the antibody repertoire.
test or training datasets of as few as 500 sequences from each replicate ( Fig. 1i ).
To estimate repertoire diversity and minimize the effects of sequencing and amplification error, we first considered clonotype diversity. An antibody clonotype is a collection of sequences using the same V and J genes, and encoding an identical CDRH3 amino acid sequence 9 . For each subject, all sequences from each biological replicate were collapsed into a set of unique clonotypes. Any clonotypes that were repeatedly observed after pooling de-duplicated biological replicates must be derived from different cells, which provides a straightforward means of quantifying multiple occurrence. For clarity, clonotypes or sequences present in multiple biological replicates from a single subject will be referred to as 'repeatedly observed' , whereas clonotypes or sequences found in multiple subjects will be referred to as 'shared' .
Rarefaction curves indicated a low frequency of repeatedly observed clonotypes, which is supported by capture-recapture sampling (3.9-11.7% recapture; Fig. 2a , Extended Data Fig. 6 ). To estimate repertoire diversity, we selected two estimators: Chao 2 and Recon. Chao 2 is a non-parametric estimator that uses repeat occurrence data from multiple samples to estimate species richness 10 . Recon uses maximum likelihood to estimate species richness, assuming only that the overall size of the repertoire is large (relative to sampling depth) and well-mixed 11 . These estimates represent the total diversity that the humoral immune system is capable of generating. Accordingly, these estimates may greatly exceed the actual number of B cells present in a single individual at any one time. The estimators produced similar estimates of clonotype diversity for each subject, with identical rank order ( Fig. 2b) . Recon consistently estimated about twofold greater repertoire diversity (2 × 10 7 -1 × 10 9 ) than Chao 2 (1 × 10 7 -5 × 10 8 ), consistent with reports that Chao 2 underestimates richness for samples with a non-negligible frequency of rare species 12, 13 . Pooling unique clonotypes from multiple subjects enabled us to estimate cohort-wide diversity (Fig. 2c ). Chao 2 (5 × 10 9 ) and Recon (5 × 10 9 ) produced nearly identical estimates for the complete ten-subject pool. Estimates of cohort-wide clonotype diversity exceed individual subject estimates by less than two orders of magnitude, which suggests a relatively high frequency of shared clonotypes. We next sought to estimate the sequence diversity for each individual, again using both the Chao 2 and Recon estimators (Fig. 2d ). As expected, the estimates for sequences were substantially higher than for clonotypes, with Chao 2 (2 × 10 8 -2 × 10 9 ) and Recon (1 × 10 8 -2 × 10 9 ) producing comparable estimates for each subject. Unlike the cohort-wide clonotype estimates, Recon estimated much lower cohort-wide sequence diversity (1 × 10 10 ) than Chao 2 (1 × 10 11 ; Fig. 2e ). The light-chain repertoire is estimated to be approximately four orders of magnitude less diverse than the heavy-chain repertoire (Extended Data Fig. 7 ) and pairing of heavy and light chains is approximately random 14 , which produces a total paired-sequence diversity estimate of 10 16 to 10 18 . The most commonly cited estimate of antibody repertoire diversity-10 12 unique sequences 2 -considers only the unmutated naive repertoire. As such, Letter reSeArCH our sequence diversity estimates, which include both the naive and memory sequences, are not directly comparable to this previous estimate. Clonotype diversity estimates-which incorporate only V-and J-gene assignments, and the CDRH3 amino acid sequence-minimize the influence of somatic hypermutation, and are more suitable for comparison with previous estimates of naive repertoire diversity. The cohort-wide paired clonotype diversity using either estimator, under the same assumptions regarding light-chain diversity and random pairing, is estimated at 3 × 10 15 -over three orders of magnitude greater than previously estimated for the naive repertoire.
Although it is known that convergent antibodies may arise from different individuals in response to immunological exposure, and a low frequency of CDRH3 sharing has previously been observed in healthy adult repertoires 9, 15 , the overall prevalence of repertoire sharing is unknown. For each combination of two or more subjects, we computed the frequency of shared clonotypes (Fig. 3a IGHV3-11  IGHV3-13  IGHV3-15  IGHV3-20  IGHV3-21  IGHV3-23  IGHV3-30  IGHV3-30-3  IGHV3-33  IGHV3-43  IGHV3-43D  IGHV3-48  IGHV3-49  IGHV3-53  IGHV3-64  IGHV3-64D  IGHV3-66  IGHV3-7  IGHV3-72  IGHV3-73  IGHV3-74  IGHV3-9  IGHV3-NL1  IGHV4-28  IGHV4-30- Letter reSeArCH subjects shared-on average-0.95% of their respective clonotypes, and 0.022% of clonotypes were shared by all ten subjects. We next used two approaches to quantify the expected frequency of clonotype sharing by chance. Hypergeometric distributions, based on cohort-wide clonotype diversity (Chao 2) and the number of unique clonotypes for each subject, indicated a low likelihood that the observed sharing was due to chance (8.8 × 10 −6 , Bonferroni-corrected P = 0.05 is 1.1 × 10 −3 ). We also generated synthetic antibody sequences using IGoR 16 to determine Letter reSeArCH the expected frequency of clonotype sharing due to coincident V(D)J recombination. Synthetic sequence sets were generated using three different recombination models: (1) IGoR's default model, inferred from unproductive antibody rearrangements and thus focused only on parameters related to V(D)J recombination; (2) subject-specific recombination models inferred from unmutated sequences from each subject; and (3) a combined-subject recombination model inferred from a pool of unmutated sequences drawn from all subjects. For each model, 10 batches of 10 8 sequences were generated, for a total of 3 billion synthetic sequences. In the sequence sets generated with IGoR's default model, clonotype sharing was sevenfold lower than in human repertoires (0.0032%; Fig. 3b ), which indicates that coincident V(D)J recombination alone is not sufficient to explain the observed sharing. The subject-derived synthetic sequence sets showed much more sharing (0.1% and 0.16%, respectively; Fig. 3b , Extended Data Fig. 8 ). In addition to containing information about V(D)J recombination, the subject-derived models also implicitly encode information about the selection processes involved in B cell development. The increased frequency of clonotype sharing in subject-derived synthetic datasets indicates that the sieving effect of B cell development produces naive repertoires that are more similar than recombination alone would be expected to produce. Combined with our observation that naiveenriched repertoires are more similar to each other than are classswitched repertoires (Fig. 1h ), a model emerges in which individual repertoires are very dissimilar after V(D)J recombination, are homogenized during B cell development and become increasingly individualized following differential responses to immunological exposure.
The length distributions of CDRH3s in unique and repeatedly observed clonotypes were similar, whereas short CDRH3s were much more common in shared clonotypes ( Fig. 3c, d ). The skew towards short CDRH3s in the shared population is probably due to the increased probability of similar recombination events among shorter CDRH3s. By contrast, repeatedly observed clonotypes are more often the result of clonal expansion, as evidenced by their increased mutation frequency (Fig. 3i ). Shared nucleotide sequences showed a strong inverse relationship between mutation frequency and the number of shared subjects (Fig. 3k ); almost all sequences shared by four or more subjects were unmutated. Thus, although coincident recombination infrequently produces identical antibody sequences, the likelihood of coincident recombination being linked to an identical set of somatic mutations is exceptionally low. Antibody CDRH3s can be divided into two primary regions: the framework-proximal 'torso' and the more-variable 'head' 17, 18 . When comparing size-matched samples of shared and unshared clonotypes, we noted less diversity in the head regions of shared clonotypes. Furthermore, head-region diversity in shared clonotypes was inversely related to length of CDRH3, which is a relationship that is not seen in unshared clonotypes or synthetic repertoires (Fig. 3e ). This inverse relationship-along with the skewed distribution of CDRH3 lengths in shared clonotypes (Fig. 3d )-indicates that two distinct processes shape the shared clonotype population. The shortest shared CDRH3s encode head-region diversity, similar to unshared CDRH3s and synthetic CDRH3s of the same length (Fig. 3f ). Thus, short CDRH3s are probably shared primarily owing to their lower CDRH3 diversity and concomitantly higher likelihood of independent generation by coincident recombination. By contrast, longer shared CDRH3s are less diverse than unshared or shared synthetic populations (Fig. 3g) , and more commonly encode head regions that are enriched in polar, uncharged residues and lack hydrophobic residues (Fig. 3h ). This implies the existence of a mechanism by which these shared clonotypes are selected or enriched after recombination, on the basis of the biochemical properties of their CDRH3 regions.
In summary, sequencing the circulating B cell population of ten individuals at unprecedented depth has revealed repertoires that are highly individualized and extremely diverse. We estimate cohort-wide repertoire diversity of approximately 5 × 10 9 unique heavy-chain clonotypes, and as many as 1 × 10 11 unique heavy-chain sequences. This indicates that the paired antibody diversity available to the circulating repertoire is very large, perhaps in the region of 10 16 -10 18 unique antibody sequences. Despite this enormous diversity, clonotypes are shared more frequently than would be expected from coincident V(D)J recombination. Furthermore, we found that clonotype sharing is probably driven primarily by selection processes related to early B cell development rather than by convergent responses to common antigens. The possible clinical and diagnostic applications of sequencing the adaptive-immune repertoire are myriadhowever, much work remains to be done before these applications can be implemented. The results described here are confined to circulating B cells, which represent a minority of the total B cell population. The repertories of circulating and tissue-resident B cells are known to differ 19 , and these differences may influence overall repertoire diversity and sharing. Furthermore, we have studied only ten individuals from a limited age range (18-30 years) and geographical region at a single time point. Much larger cohorts-representing diverse ethnicities, geographies and ages-will be required to capture the true populationwide repertoire diversity. Nevertheless, large-scale sequencing of the human adaptive-immune repertoire holds immense potential. Our use of high-level antibody-feature frequencies to differentiate repertoires raises the possibility of identifying and classifying discrete repertoire perturbations associated with autoimmune disease and chronic infection. Furthermore, because the repertoire of adaptiveimmune receptors encodes a comprehensive record of an individual's immunological encounters, leveraging large-scale sequencing of adaptive-immune receptors represents an appealing strategy for diagnosing infection or deconvoluting infection histories. Finally, the individuality of the baseline repertoire of each subject suggests that the personalization of vaccine delivery and therapeutic intervention may produce substantial benefits in the treatment and prevention of infectious diseases.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. Leukapheresis samples. Full leukopaks (three blood volumes) were obtained from ten human subjects (Hemacare). Samples were collected at Hemacare's Southern California donor centre. Sample collection was performed under a protocol approved by the Institutional Research Boards of Scripps Research and Hemacare. Informed consent was obtained from each subject. All subjects were healthy, HIVnegative adults between the ages of 18 and 30 with no reported acute illness in the 14 days before leukapheresis. The subject pool was gender-balanced and evenly divided between African-American and Caucasian individuals (ethnicity was self-reported; Extended Data Table 1 ). Immediately upon receipt of the leukopak, peripheral blood mononuclear cells were purified by gradient centrifugation and cryo-preserved. Amplification strategy and primer bias. We elected to use RNA as the template for antibody variable gene amplification, as this focuses our analysis on productive heavy-chain rearrangements and permits the use of amplification primers that anneal to the CH1 region (owing to the presence of an intron between the JH gene and CH region, the use of CH1 primers is not feasible when amplifying from DNA). The decision to use RNA has some inherent downsides, however-primarily the likelihood of overrepresentation of transcriptionally active B cells (namely, memory B cells and plasmablasts). It should be noted that the use of molecular barcodes, which enable identification and collapsing of reads that originate from the same RNA molecule, will not correct this problem. To reduce the influence of multiplexed primer sets on the resulting composition of antibody genes that are amplified, we designed an amplification strategy that limits the use of multiplexed primers that anneal to the V-gene region in an attempt to reduce primer bias during amplification. Following cDNA synthesis, second-strand synthesis was performed using multiplexed V-gene primers that encode an overhang that comprises a portion of the Illumina adapters required for next-generation sequencing. V-gene primers were then enzymatically removed before subsequent amplification of the antibody genes using the conserved overhang as the primer annealing site. Thus, the multiplexed V-gene primers were only used for a single round of amplification. Antibody gene amplification. For each subject, total RNA was separately isolated from 6 aliquots of approximately 5 × 10 8 cryo-preserved peripheral blood mononuclear cells (RNeasy Maxi, Qiagen). For each RNA aliquot, antibody genes were amplified in triplicate (18 total samples per subject), with each of the technical replicates processed independently and starting with a separate aliquot of the RNA sample. To minimize the likelihood of crosscontamination between subjects, reverse transcription and PCR reactions for each subject were processed in isolation, such that samples from two different subjects were never in proximity during amplification reaction preparation. All primers 20 are listed in Extended Data Table 2 . To increase the sequencer-perceived nucleotide diversity during each sequencing cycle, 'offsets' were added to the reverse-transcription and second-strand synthesis primers. Three sets of these primers were synthesized, with each set containing 2, 4 or 6 random nucleotides at the offset position (see Extended Data Table 2 ). These offsets stagger the conserved constant and framework regions and result in much higher diversity during each sequencing cycle, and minimize the required PhiX spike. cDNA synthesis was performed on 11 μl of RNA using 10 pmol of each primer in a 20-μl total reaction (SuperScript III, Thermo Fisher Scientific), using the manufacturer's protocol and the following thermal cycling program: 55 °C for 60 min, 70 °C for 15 min. Residual primers and dNTPs were degraded enzymatically (ExoSAP-IT, Thermo Fisher Scientific), according to the manufacturer's protocol. The entire enzyme-treated cDNA synthesis product was used in a 100-μl second-strand synthesis reaction using 10 pmol of each primer (HotStarTaq Plus, Qiagen) using the following thermal cycling protocol: 95 °C for 5 min, 55 °C for 30 s, 72 °C for 10 min. Residual primers and dNTPs were again degraded enzymatically (ExoSAP-IT) and dsDNA was purified using 0.8 volumes of SPRI beads (AmpureXP, Beckman Coulter Genomics) and eluted in 50 μl of water. Antibody genes were amplified using 40 μl of eluted dsDNA and 10 pmol of each primer in a 100-μl total reaction volume (HotStarTaq Plus), using the following thermal cycling program: 95 °C for 5 min; 25 cycles of: 95 °C for 30 s, 58 °C for 30 s, 72 °C for 2 min; 72 °C for 10 min. DNA was purified from the PCR reaction product using 0.8 volumes of SPRI beads (AmpureXP) and eluted in 50 μl of water. Subsequently, 10 μl of the eluted PCR product was used in a final indexing PCR (HotStarTaq Plus) using 10 pmol of each primer in 100-μl total reaction volume and using the following thermal cycling program: 95 °C for 5 min; 10 cycles of: 95 °C for 30 s, 58 °C for 30 s, 72 °C for 2 min; 72 °C for 10 min. PCR products were purified with 0.7 volumes of SPRI beads (SPRIselect, Beckman Coulter Genomics) and the entire set of samples from a single subject was eluted in a single 120-μl volume of water. Sequencing. SPRI-purified sequencing libraries were initially quantified using fluorometry (Qubit, Thermo Fisher Scientific) before size determination using a Bioanalyzer (Agilent 2100). Libraries were requantified using qPCR (KAPA Biosystems) before sequencing on an Illumina HiSeq 2500 using 2 × 250-bp Rapid Run chemistry. Raw sequence processing. Raw paired FASTQ files were quality checked with FASTQC (www.bioinformatics.babraham.ac.uk/projects/fastqc/). Because the 5′ end of each paired read encodes the unique molecular identifier (UMI), reads were quality trimmed only at the 3′ end using Sickle (www.github.com/najoshi/ sickle), using a window size of 0.1 times the length of the read, minimum average window quality score of 20, and a minimum read length after trimming of 50 nucleotides. Because UMIs are located on the 'outside' of the gene-specific primers used for amplification (see Extended Data Fig. 1b) , primer trimming was delayed until after UMI processing. Processed reads were quality checked again using FASTQC, and paired reads were merged with PANDAseq using the default (simple_bayesian) merging algorithm 21 . Molecular barcodes. Although sequencing libraries were constructed to encode molecular barcodes on both ends of the amplicon, we observed low-level PCR recombination 22 that produced 'barcode swapping' , causing the frequency of these amplification artefacts to be amplified. In essence, a partial amplification productcomposed of a CDRH3 and an incomplete VH gene-was able to prime a different antibody sequence and continue amplification, producing a hybrid VH gene. This hybrid amplicon encodes the 3′ molecular barcode from the primary antibody recombination and the 5′ molecular barcode from the second. The barcode swapping creates a unique barcode pair, forcing the hybrid sequence to be binned and processed separately. To minimize the effects of such barcode swapping, we binned sequences using only the 3′ molecular barcode. Because the likelihood of UMI collisions was relatively high given the sequencing depth, the CDRH3 nucleotide sequences of each UMI bin containing more than one sequence were clustered at high identity (90%) and a consensus sequence was computed for each cluster. For UMI bins containing only a single sequence, the lone sequence was used as the representative for the respective UMI bin. Because our sequencing depth was approximately equal to the number of input cells (~3 × 10 8 sequencing reads from ~3 × 10 8 input B cells), the majority of UMI bins contained only a single sequencing read. As such, the UMIs were not used primarily for error correction, but as a means for correcting differential representation arising from stochastic or primer-driven amplification biases. Mutation frequencies in the IgM and IgG sequence populations (Extended Data Fig. 3 ) provide empirical evidence of a low amplification and sequencing error rate that corroborates sequencer-derived quality metrics. Germline gene assignment and annotation. Adapters and V-gene amplification primers (used for second-strand synthesis) were removed using cutadapt 23 . cDNA synthesis primers, which anneal to the CH1 region, were not removed because this region is needed to determine the isotype. Sequences were annotated with abstar 4 and two output formats were generated: a comprehensive JSON-formatted output, which was imported into a MongoDB database; and a minimal CSV-formatted output, which is tabular and suitable for direct parsing or conversion to Parquet for querying on a Spark cluster. Antibody clonotypes. Antibody clonotypes, defined as a collection of sequences that use the same V and J germline segments and encode an identical CDRH3 amino acid sequence, were used throughout this study to reduce the influence of sequencing or amplification error. Although collapsing the V or J regions to just the germline assignment removes the possibility of double-counting sequences that differ only by error(s) in the V-or J-gene region, it does not eliminate the effect of error in the CDRH3 sequence. To gauge the effect of sequencing and amplification error in CDRH3 on clonotype diversity, we collapsed sequences into clonotypes allowing either no mismatches in the CDRH3 amino acid sequence or a single mismatch in the CDRH3 sequence. The total number of one-mismatch clonotypes was lower than the number of zero-mismatch clonotypes by only 5.9% on average (3.4-9.5%), which is as expected when collapsing a sequence population that contains expanded antibody lineages (Extended Data Fig. 5 ), and indicates that CDRH3 sequencing errors do not contribute meaningfully to clonotype diversity. Thus, only zero-mismatch clonotypes were used for all further experiments using clonotypes. Estimation of light-chain diversity relative to heavy chain diversity. Estimation of light-chain diversity is in some ways more complex than estimating heavychain diversity, owing to the relatively high frequency of coincidentally identical recombinations 14 . Rather than sequencing unpaired light chains and attempting to discern independent rearrangements from distinct copies of RNA derived from the same recombination event, we leveraged a novel dataset of paired antibody heavy and light chains to estimate the diversity of light chains relative to the diversity of heavy chains 14 . For each of the three subjects for which paired heavy-and light-chain sequencing data were available, we estimated the total richness using Chao 2 and Recon estimators. Each subject was sequenced in duplicate, and separated estimates were computed for each sequencing replicate. Because the sequencing depth was far lower in the paired dataset than in the large-scale experiment described here, we extrapolated the richness estimates so that the paired richness estimates were more comparable with the large-scale estimates. Although such an extrapolation may introduce a non-trivial amount of variance into the richness estimates, we believe that this provides the most accurate estimate of relative light-chain diversity that is currently available. Diversity estimates and the associated extrapolations can be found in Extended Data Fig. 7 . The highest ratio of heavy-chain to light-chain richness (indicating the lowest diversity of light chains relative to heavy chains) was observed with the Chao 2 estimator (3.8 × 10 3 ). Conservatively, we rounded this ratio up to the nearest order of magnitude (10 4 ) when computing the total paired repertoire diversity estimates. Generating synthetic repertoires based on a probabilistic model of V(D)J recombination. We created a total of 3 billion synthetic antibody sequences using IGoR 16 with one of three different approaches. First, we created 10 sequence batches-each containing 10 8 synthetic antibody sequences-using IGoR's default recombination model, which was inferred from unproductive antibody rearrangements. The reason for using unproductive rearrangements for inferring IGoR's default recombination model is that productive rearrangements are subject to a variety of selection processes during B cell maturation (negative selection of autoreactive clones, requirement for productive pairing with a light chain, and so on), whereas unproductive rearrangements are subject to none of these selection processes. Thus, a model inferred from unproductive rearrangements incorporates only information about the V(D)J recombination process. Second, we inferred subject-specific recombination models using 5 × 10 5 randomly selected IgM sequences that were entirely unmutated in the V-gene region. Ten synthetic sequence batches, each containing 10 8 sequences, were then generated-one batch per subject. Finally, we inferred a combined-subject recombination model using a pool of 5 × 10 5 umutated IgM sequences from all 10 subjects (5 × 10 4 sequences per subject, randomly selected from the sequences used to generate the subject-specific models). As with IGoR's default model, 10 separate batches of 10 8 synthetic sequences were generated with the combined-subject model. All synthetic sequences were processed in the same manner as the observed antibody sequences, except that the adapter trimming and UMI-based correction steps were not performed. Kullback-Leibler divergence between models or model 'events' was computed with the pygor package, which is distributed with IGoR (Extended Data Fig. 8 ). Morisita-Horn similarity. Antibody sequences from each subject were reduced to only the V-gene, J-gene and CDRH3 length (and were randomly subsampled with replacement at sample sizes ranging from 10 1 to 10 7 ). The frequency of each V-gene, J-gene and CDRH3 length was computed, and the frequency distributions from two donors were used to compute the Morisita-Horn similarity index:
in which x i is the number of times the V-gene, J-gene and CDRH3 length i is represented in one sample of size X; and y i is the number of times the V-gene, J-gene and CDRH3 length i is represented in a second sample of size Y. Rarefaction. For each subject, all unique clonotypes from each of the biological replicates were pooled. For varying sample sizes (ranging from 0.1 to 1.0 as a fraction of the total number of pooled clonotypes), samples were randomly drawn without replacement and the number of unique clonotypes in the sample was computed. For each sample size, a total of 10 independent samplings were performed, with the exception of the 1.0 fraction, which was only sampled once (as samplings of the entire dataset will always produce the same result). Classification of repertoires by subject. Repertoires were classified using a oneversus-rest support-vector-machine classifier. Classifier training and evaluation were performed in Python using the scikit-learn framework. It is important to note that this classification was performed using only ten subjects and expanding the subject pool to thousands or millions of individuals, while maintaining classifier accuracy, would likely require much larger training datasets and/or the inclusion of additional sequence features to supplement the V-gene, J-gene and CDRH3 length. Additionally, because the repertoire of each subject will be altered by new immunological encounters and ongoing turnover in the naive B cell population, it is possible that these high-level sequence feature frequencies will change substantially over time. 
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Extended Data Fig. 3 | Nucleotide mutation frequencies. a, The distribution of nucleotide mutations in sequences that encode IgM are shown. On the right, the number of unmutated sequences containing no mutations in the variable-gene segment is also plotted. b, The distribution of nucleotide mutations in sequences that encode IgG are shown. On the right, the mean mutation frequency for the IgG population of each subject is shown. Each line represents a single subject. For legibility, the legend is split between the two plots. Although only five subjects are shown in the legend of each plot, data from all ten subjects is present in each plot.
Extended Data Fig. 5 | Collapsing sequences into clonotypes. a,
To demonstrate the effect of collapsing an expanded clonal lineage into clonotypes, we selected a previously reported lineage of Zika-specific monoclonal antibodies isolated from the plasmablast population of an acutely infected patient 24 . Of 119 sequences, 89 were unique at the nucleotide level. b, Sequences encoding the same V gene, J gene and an identical CDRH3 amino acid sequence were collapsed into clonotypes, and the sequence phylogeny was coloured by clonotype. A total of 119 sequences were collapsed into 18 clonotypes. c, Sequences were collapsed into clonotypes, allowing a single mismatch in the CDRH3 amino acid sequence, and the sequence phylogeny was coloured by clonotype. A total of 119 sequences were collapsed into 10 clonotypes. d, The clonotype fraction (number of clonotypes divided by the total number of filtered sequences), when collapsing clonotypes while allowing zero or one mismatch in the CDRH3 amino acid sequence for each subject in this study. e, Number of total clonotypes recovered when allowing zero or one mismatch in the CDRH3 amino acid sequence for each subject in this study.
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Extended Data Fig. 7 | Relative light-chain diversity estimation. Using previously reported datasets of paired heavy and light antibody chains, clonotype diversity was estimated for heavy and light chains using both Chao 2 and Recon estimators. Estimates are shown in filled or unfilled points. Lines indicate the least-squares polynomial best fit (degree = 2) and is extrapolated to include both the lowest (1.17 × 10 8 ) and highest (9.06 × 10 8 ) number of UMI-corrected sequences from the 10 sequenced subjects.
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